SHENZHEN HEPALINK PHARMACEUTICAL revenue breakdown overview

SHENZHEN HEPALINK PHARMACEUTICAL revenue for the last year amounted to 5.88 B HKD, the most of which — 3.29 B HKD — came from its highest performing source at the moment, Preparation, the year earlier bringing 3.73 B HKD. The greatest contribution to the revenue figure was made by Europe — last year it brought SHENZHEN HEPALINK PHARMACEUTICAL 2.89 B HKD, and the year before that — 4.34 B HKD.